Cadence Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.09M | Buy |
|
|||||
|
2020
Q1 | $1.31M | Sell |
|
|||||
|
2019
Q4 | $2.12M | Sell |
|
|||||
|
2019
Q3 | $2.92M | Sell |
|
|||||
|
2019
Q2 | $3.31M | Sell |
|
|||||
|
2019
Q1 | $4.28M | Buy |
|
|||||
|
2018
Q4 | $2.7M | Buy |
|
|||||
|
2018
Q3 | $3.13M | Buy |
|
|||||
|
2018
Q2 | $3.08M | Buy |
|
|||||
|
2018
Q1 | $1.47M | Buy |
|
|||||
|
2017
Q4 | $1.57M | Sell |
|
|||||
|
2017
Q3 | $1.75M | Buy |
|
|||||
|
2017
Q2 | $299K | Buy |
|
|||||
|
2017
Q1 | $300K | Sell |
|
|||||
|
2016
Q4 | $515K | Sell |
|
|||||
|
2016
Q3 | $1.12M | Sell |
|
|||||
|
2016
Q2 | $946K | Buy |
|
|||||
|
2016
Q1 | $552K | Buy |
|
|||||
|
2015
Q4 | $331K | Sell |
|
|||||
|
2015
Q3 | $309K | Sell |
|
|||||
|
2015
Q2 | $631K | Sell |
|
|||||
|
2015
Q1 | $1.04M | Buy |
|